• Japanese
  • Korean
  • Chinese
Home > Pharmaceutical > Infectious Disease Market Research Reports
Category
Pharmaceutical (4432)
Cancer (965)
Diabetes (168)
Drug Delivery System (123)
Drug Discovery (1603)
Drug Regulation (109)
Generic Drugs (84)
Infectious Disease (307)
Neurodegenerative Disease (186)
OTC Drug (91)
Pharmaceutical Companies (236)
Prescription Drugs (369)
Vaccines (206)

Infectious Disease Market Research Reports

Renewed interest from governments and the private sector in infectious diseases has shifted the industry into high gear. For all your information needs regarding disease testing, vaccines, therapeutics, and infectious disease-related R&D, you may wish to view our up-to-date reports, which will help you to understand technologies and markets in the field.

Filter
Title Search
1 - 25 of 307 Products Sort by Display
Hepatitis Drugs Markets in China
Product code:299933
Published by Asia Market Information & Development
Published April 16, 2014 Price USD 4000
Content info 170 Pages
Sample available
Diagnostics and Therapeutics for HIV: Global Markets
Product code:180820
Published by BCC Research
Published April 11, 2014 Price USD 6650
Content info 163 Pages
Sample available
The aim of this report is to provide detailed market, technology and industry analyses to help readers quantify and qualify the market for products used in the management of HIV infection....
*
Product code:292629
Published by Doctor's Guide Publishing Limited (FirstWord Pharma)
Published April 1, 2014 Price USD 4995
Content info 163 pages
Sample available
Human papillomavirus (HPV) Associated Cancer Global Clinical Trials Review, H1, 2014
Product code:298074
Published by GlobalData
Published March 19, 2014 Price USD 2500
Content info 121 Pages
Sample available
Antibacterial Drugs: World Industry and Market Prospects 2014-2024
Product code:226947
Published by Visiongain
Published March 4, 2014 Price USD 2788
Content info 313 Pages
Sample available
What are the commercial prospects for antibacterial treatments? Visiongain's report shows you potential revenue values to 2022. Find data, forecasts and discussions....
Influenza Partnering 2009-2014
Product code:263864
Published by Current Partnering, a division of Wildwood Ventures Limited
Published March 1, 2014 Price USD 1795
Content info  
Sample available
*
Product code:263863
Published by Current Partnering, a division of Wildwood Ventures Limited
Published March 1, 2014 Price USD 1795
Content info  
Sample available
Viral Partnering Terms and Agreements
Product code:246683
Published by Current Partnering, a division of Wildwood Ventures Limited
Published March 1, 2014 Price USD 1995
Content info 456 Pages
Sample available
Infectives Partnering Terms and Agreements
Product code:246679
Published by Current Partnering, a division of Wildwood Ventures Limited
Published March 1, 2014 Price USD 2995
Content info 803 Pages
Sample available
Antiviral Therapeutics - technologies, markets and companies
Product code:70939
Published by Jain Pharmabiotech
Published March 1, 2014 Price USD 4000
Content info  
This report reviews the current state-of-art of antiviral approaches including vaccines, pharmaceuticals and innovative technologies for delivery of therapeutics....
AIDS - Related Primary CNS Lymphoma Global Clinical Trials Review, H1, 2014
Product code:296849
Published by GlobalData
Published February 26, 2014 Price USD 2500
Content info 48 Pages
Sample available
AIDS - Related Kaposi's Sarcoma Global Clinical Trials Review, H1, 2014
Product code:296848
Published by GlobalData
Published February 26, 2014 Price USD 2500
Content info 91 Pages
Sample available
AIDS - Related Lymphoma Global Clinical Trials Review, H1, 2014
Product code:296847
Published by GlobalData
Published February 26, 2014 Price USD 2500
Content info 76 Pages
Sample available
*
Product code:292627
Published by Doctor's Guide Publishing Limited (FirstWord Pharma)
Published February 24, 2014 Price USD 7495
Content info 183 Pages + Data File
Sample available
Global Infectious Diseases Therapeutics Market-Influenza, RSV, Chlamydia, and Gonorrhoea
Product code:296617
Published by Frost & Sullivan
Published February 14, 2014 Price USD 4500
Content info 137 Pages
Sample available
PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Current and Future Players
Product code:299715
Published by GlobalData
Published January 31, 2014 Price USD 2995
Content info 70 Pages
Sample available
Twinrix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022
Product code:299171
Published by GlobalData
Published January 31, 2014 Price USD 3495
Content info 67 Pages
Sample available
Recombivax HB (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022
Product code:299170
Published by GlobalData
Published January 31, 2014 Price USD 3495
Content info 68 Pages
Sample available
Pediarix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022
Product code:299169
Published by GlobalData
Published January 31, 2014 Price USD 3495
Content info 65 Pages
Sample available
Infanrix Hexa (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022
Product code:299168
Published by GlobalData
Published January 31, 2014 Price USD 3495
Content info 65 Pages
Sample available
Hexyon (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022
Product code:299167
Published by GlobalData
Published January 31, 2014 Price USD 3495
Content info 66 Pages
Sample available
Heplisav (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022
Product code:299166
Published by GlobalData
Published January 31, 2014 Price USD 3495
Content info 91 Pages
Sample available
Fendrix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022
Product code:299165
Published by GlobalData
Published January 31, 2014 Price USD 3495
Content info 64 Pages
Sample available